JF
RLAY icon

Jump Financial’s Relay Therapeutics RLAY Stock Holding History

Jump Financial’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-82,559
Closed -$698K – 2327
2025
Q4 		$698K Buy
+82,559
New +$589K 0.01% 1140
2025
Q3 		– Sell
-15,301
Closed -$52.9K – 2162
2025
Q2 		$52.9K Buy
+15,301
New +$45.5K ﹤0.01% 1695
2025
Q1 		– Sell
-138,226
Closed -$569K – 1957
2024
Q4 		$569K Buy
138,226
+36,251
+36% +$197K 0.01% 1018
2024
Q3 		$722K Buy
+101,975
New +$762K 0.01% 954
2024
Q2 		– Sell
-10,316
Closed -$85.6K – 2189
2024
Q1 		$85.6K Buy
+10,316
New +$101K ﹤0.01% 1805
2023
Q4 		– Sell
-103,194
Closed -$868K – 2173
2023
Q3 		$868K Sell
103,194
-13,313
-11% -$143K 0.03% 742
2023
Q2 		$1.46M Buy
+116,507
New +$1.45M 0.05% 507
2023
Q1 		– Sell
-92,413
Closed -$1.38M – 1979
2022
Q4 		$1.38M Buy
+92,413
New +$1.77M 0.07% 361
2022
Q1 		– Sell
-10,700
Closed -$329K – 1854
2021
Q4 		$329K Sell
10,700
-59,400
-85% -$1.88M 0.02% 841
2021
Q3 		$2.21M Buy
70,100
+51,975
+287% +$1.75M 0.16% 124
2021
Q2 		$663K Buy
+18,125
New +$597K 0.06% 380

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Jump Financial's RLAY Position: Q1 2026 in Review

Jump Financial sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 82,559 shares — an estimated $698K sold.

Jump Financial first reported a position in RLAY in Q2 2021 and held it in 11 quarters. The position peaked at $2.21M in Q3 2021. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Jump Financial reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 82,559 Relay Therapeutics shares in Q1 2026, an estimated $698K.
  • Jump Financial first reported a position in Relay Therapeutics in Q2 2021 and held it in 11 quarters.
  • Jump Financial's Relay Therapeutics position peaked at $2.21M in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.